Galderma Group AG (VIE:GALD)

Austria flag Austria · Delayed Price · Currency is EUR
177.00
+1.00 (0.57%)
At close: Dec 23, 2025
16.45%
Market Cap41.91B
Revenue (ttm)3.99B
Net Income (ttm)321.87M
Shares Outn/a
EPS (ttm)1.35
PE Ratio130.22
Forward PE50.05
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open176.00
Previous Close176.00
Day's Range176.00 - 177.00
52-Week Range149.00 - 180.00
Betan/a
RSI62.99
Earnings DateJul 23, 2026

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology. ... [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 6,545
Stock Exchange Vienna Stock Exchange
Ticker Symbol GALD
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.